Phase III study of all-trans retinoic acid in previously untreated patients 61 years or older with acute myeloid leukemia

S Fröhling, F Hartmann, JT Fischer, A Glasmacher… - Leukemia, 2004 - nature.com
The purpose of our study was (i) to evaluate the impact of all-trans retinoic acid (ATRA)
given as adjunct to chemotherapy and (ii) to compare second consolidation vs maintenance …
被引用次数：216 相关文章

[引用][C] Phase III study of all-trans retinoic acid in previously untreated patients 61 years or older with acute myeloid leukemia

S RF - Leukemia, 2004 - cir.nii.ac.jp
Phase III study of all-trans retinoic acid in previously untreated patients 61 years or older with
acute myeloid leukemia | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] …

Phase III study of all-trans retinoic acid in previously untreated patients 61 years or older with acute myeloid leukemia

RF Schlenk, S Frohling, F Hartmann, JT Fischer… - 2004 - mediatum.ub.tum.de
The purpose of our study was (i) to evaluate the impact of all-trans retinoic acid (ATRA)
given as adjunct to chemotherapy and (ii) to compare second consolidation vs maintenance …

Phase III study of all-trans retinoic acid in previously untreated patients 61 years or older with acute myeloid leukemia

RF Schlenk, S Frohling, F Hartmann, JT Fischer… - Leukemia, 2004 - go.gale.com
The purpose of our study was (i) to evaluate the impact of all-trans retinoic acid (ATRA)
given as adjunct to chemotherapy and (ii) to compare second consolidation vs maintenance …

Phase III study of all-trans retinoic acid in previously untreated patients 61 years or older with acute myeloid leukemia.

RF Schlenk, S Fröhling, F Hartmann… - Leukemia …, 2004 - search.ebscohost.com
The purpose of our study was (i) to evaluate the impact of all-trans retinoic acid (ATRA)
given as adjunct to chemotherapy and (ii) to compare second consolidation vs maintenance …

Phase III study of all-trans retinoic acid in previously untreated patients 61 years or older with acute myeloid leukemia

RF Schlenk, S Fröhling, F Hartmann… - …, 2004 - pubmed.ncbi.nlm.nih.gov
The purpose of our study was (i) to evaluate the impact of all-trans retinoic acid (ATRA)
given as adjunct to chemotherapy and (ii) to compare second consolidation vs maintenance …
[PDF] academia.edu

[PDF][PDF] Phase III study of all-trans retinoic acid in previously untreated patients 61 years or older with acute myeloid leukemia

RF Schlenk, S Fröhling, F Hartmann, JT Fischer… - Leukemia, 2004 - academia.edu
The purpose of our study was (i) to evaluate the impact of alltrans retinoic acid (ATRA) given
as adjunct to chemotherapy and (ii) to compare second consolidation vs maintenance …

Phase III study of all-trans retinoic acid in previously untreated patients 61 years or older with acute myeloid leukemia.

RF Schlenk, S Fröhling, F Hartmann, JT Fischer… - Leukemia, 2004 - europepmc.org
The purpose of our study was (i) to evaluate the impact of all-trans retinoic acid (ATRA)
given as adjunct to chemotherapy and (ii) to compare second consolidation vs maintenance …

[引用][C] Phase iii study of all-trans retinoic acid in previously untreated patients 61 years or older with acute myeloid leukemia

RF SCHLENK, S FRÖHLING, H PRALLE… - …, 2004 - pascal-francis.inist.fr
Author SCHLENK, R. F 1; FRÖHLING, S 1; PRALLE, H 10; MERGENTHALER, H. G 6;
HANSEL, M 11; KOLLER, E 12; KIRCHEN, H 13; PREISS, J 14; SALWENDER, H 15; …

[引用][C] Phase iii study of all-trans retinoic acid in previously untreated patients 61 years or older with acute myeloid leukemia

RF SCHLENK, S FRÖHLING, F HARTMANN… - …, 2004 - Nature Publishing Group